Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Kailera Therapeutics Plans IPO for Obesity Drug
Announced
HealthcareOther
Deal Overview
Kailera Therapeutics plans an IPO focused on an obesity drug candidate intended to compete in the Zepbound category. The company’s public-market plans center on bringing its obesity-treatment program forward through a listing.
No pricing, proceeds, or terms are included in the provided material.
Key Details
- Target
- Kailera Therapeutics
Related Deals
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. for €7.5m to Expand EU Reach - scanx.trade
HealthcareAdd-on
Marksans Pharma→QliniQ
Jun 1, 2026
Altruix Acquired By Frazier Healthcare Partners And Randy Hyun Appointed CEO - Pulse 2.0
HealthcareOther
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
HealthcareOther
Signos
May 31, 2026
Sterling Bay Partnership Secures $290M Financing for Sorrento Mesa’s Pacific Center
HealthcareCaliforniaOther
Sterling Bay→Pacific Center
May 29, 2026